Although 1 in 7 adults smoke cigarettes the year prior to undergoing weight-loss surgery, nearly all successfully quit at least a month before their operation. However, smoking prevalence steadily climbs to pre-surgery levels within seven years, according to new research.
Surgical treatment of obesity is as effective for individuals who developed the disorder early, by the age of 20, as for those who have developed obesity later in life, a study from the University of Gothenburg shows.
While researchers pursue scientific insights into the pancreatic cancer and develop new therapeutic approaches, surgeons on the front line of patient care are also working hard to improve outcomes.
Hari Nathan, M.D., Ph.D., an assistant professor of surgery at Michigan Medicine, explains.
The first set of comprehensive, evidence-based clinical guidelines for surgical treatment of thyroid disease – developed by an expert panel assembled by the American Association of Endocrine Surgeons (AAES) – was published today by Annals of Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.
A pilot program introducing bundled payments for hip and knee replacement (HKR) in Medicare patients hasn’t led hospitals to “cherry-pick” healthier patients at lower risk of complications, reports a study in the February 19, 2020 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
John Theurer Cancer Center at Hackensack University Medical Center is the only site in New Jersey and one of just 17 in the country participating in a multicenter international Phase II study of an innovative personalized cancer vaccine being evaluated in combination with pembrolizumab immunotherapy in patients with melanoma that has been surgically removed but has a high risk of coming back. The hope is that the vaccine can prime a patient's immune system to be more responsive to immunotherapy and reduce the risk of cancer recurrence.
University Hospitals (UH) has appointed Alejandro Rivas, M.D., to be Division Chief of Otology/Neurotology in the UH Department of Otolaryngology – Head and Neck Surgery.
He joins UH on June 1, 2020 from Vanderbilt University Medical Center in Nashville, Tenn., where he is Director of Endoscopic Ear Surgery
Dr. Rivas is one of the foremost pioneers of endoscopic ear surgery in the world. He has performed and taught endoscopic ear surgery and cochlear implant surgical approaches across the globe, including Colombia, Italy, Argentina, Japan, and Australia. This type of surgery results in less invasive procedures for patients with chronic ear disease.